The Next Chapter of Science - Independant Express independantexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from independantexpress.com Daily Mail and Mail on Sunday newspapers.
NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Get latest articles and stories on Health at LatestLY. Immune checkpoint inhibitors such as Keytruda and Opdivo work by unleashing the immune system s T cells to attack tumour cells. Their introduction a decade ago marked a major advance in cancer therapy, but only 10 per cent to 30 per cent of treated patients experience long-term improvement. New findings could now bolster the effectiveness of immune-checkpoint therapy. Health News | Researchers Develop Promising New Cancer Therapy.
Immune checkpoint inhibitors like Opdivo and Keytruda function by releasing the T cells of the immune system to attack tumour cells. Although its release ten ye